Tradipitant Approved As First New Treatment For Motion Sickness In 40 Years

Tradipitant Approved As First New Treatment For Motion Sickness In 40 Years

Credit: Canva/Tradeindia.com

Text

Updated May 4, 2026 | 10:48 AM IST

SummaryMotion sickness affects an estimated 65 to 78 million Americans—roughly 25 to 30 percent of adults—during everyday travel by car, plane, or boat. For decades, patients have had no meaningful new treatment options.

End of Article